Estimating window period blood donations for human immunodeficiency virus Type1, hepatitisC virus, and hepatitisB virus by nucleic acid amplification testing in Southern Pakistan

Transfusion

Volumn 54, Issue 6, 2014, Pages 1652-1659

  Moiz, Bushra ^a   Moatter, Tariq ^a   Shaikh, Usman ^a   Adil, Salman ^a   Ali, Natasha ^a   Mahar, Farheen ^a   Shamsuddin, Naseem ^a   Khurshid, Mohammad ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; NUCLEIC ACID AMPLIFICATION; PAKISTAN; RISK FACTOR; SCREENING; SEROLOGY; SEROPREVALENCE; VIRUS LOAD;

ALGORITHMS; HEPACIVIRUS; HEPATITIS B VIRUS; HIV-1; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAKISTAN;

EID: 84902253747     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12521     Document Type: Article

References (30)

1. Ali N, Moinuddin, Ahmed SA, etal. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non-reactive blood donors with normal alanine aminotransferase. J Coll Physicians Surg Pak 2010; 20: 662-666.
2. Ali N, Moiz B, Moatter T, etal. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors. Indian J Pathol Microbiol 2010; 53: 480-485.
3. Bhatti FA, Ullah Z, Salamat N, etal. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47: 74-79.
4. Ali SA, Donahue RM, Qureshi H, etal. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009; 13: 9-19.
5. Khan AA, Khan A,. The HIV epidemic in Pakistan. J Pak Med Assoc 2010; 60: 300-307.
6. Kosan E, Kocazeybek B, Altunay H, etal. Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent. Transfus Apher Sci 2010; 43: 269-272.
7. Phikulsod S, Oota S, Tirawatnapong T, etal. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49: 1126-1135.
8. Busch MP, Glynn SA, Stramer SL, etal. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-264.
9. Comanor L, Holland P,. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91: 1-12.
10. Fiebig EW, Wright DJ, Rawal BD, etal. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-1879.
11. Nubling CM, Unger G, Chudy M, etal. Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion 2002; 42: 1037-1045.
12. Whalley SA, Murray JM, Brown D, etal. Kinetics of acute hepatitis B virus infection in humans. J Exp Med 2001; 193: 847-854.
13. O'Brien SF, Yi QL, Fan W, etal. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007; 47: 316-325.
14. Attaullah S, Khan S, Khan J,. Trend of transfusion transmitted infections frequency in blood donors: provide a road map for its prevention and control. J Transl Med 2012; 10: 20.
15. Zeissig S, Murata K, Sweet L, etal. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 2012; 18: 1060-1068.
16. Chowdhury A, Santra A, Chaudhuri S, etal. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37: 802-809.
17. Sultan F, Mehmood T, Mahmood MT,. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007; 11: 407-412.
18. Abraham P,. Viral hepatitis in India. Clin Lab Med 2012; 32: 159-174.
19. Senevirathna D, Amuduwage S, Weerasingam S, etal. Hepatitis C virus in healthy blood donors in Sri Lanka. Asian J Transfus Sci 2011; 5: 23-25.
20. Makroo RN, Choudhury N, Jagannathan L, etal. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008; 127: 140-147.
21. Jain R, Aggarwal P, Gupta GN,. Need for nucleic acid testing in countries with high prevalence of transfusion-transmitted infections. ISRN Hematol 2012; 2012: 718671.
22. Chatterjee K, Coshic P, Borgohain M, etal. Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. Natl Med J India 2013; 25: 207-209.
23. Agarwal N, Chatterjee K, Coshic P, etal. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India. Transfus Apher Sci 2013; 49: 482-484.
24. Jackson BR, Busch MP, Stramer SL, etal. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-729.
25. Hourfar MK, Jork C, Schottstedt V, etal. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008; 48: 1558-1566.
26. Mine H, Emura H, Miyamoto M, etal. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003; 112: 145-151.
27. El Ekiaby M, Lelie N, Allain JP,. Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals 2010; 38: 59-64.
28. Ren FR, Wang JX, Huang Y, etal. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 2011; 51: 2588-2595.
29. Lefrere JJ, Dahourouh H, Dokekias AE, etal. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011; 51: 486-492.
30. Luby S, Khanani R, Zia M, etal. Evaluation of blood bank practices in Karachi, Pakistan, and the government's response. J Pak Med Assoc 2006; 56: S25-30.